Global Point-of-Care Testing (POCT) Devices Market Size By Type (Hospital POCT equipment, Home POCT equipment), By Application (Application I, Application II), By Region, And Segment Forecasts, 2023 t...

lobal Point-of-Care Testing (POCT) Devices Market Report Description

The Global Point-of-Care Testing (POCT) Devices Market was valued at USD 40.2 billion in 2023 and is projected to surpass USD 72.8 billion by 2031, growing at a CAGR of 7.6% during the forecast period of 2023-2031.

The market growth is driven by the rising demand for rapid diagnostics, increasing prevalence of chronic and infectious diseases, and the shift toward decentralized healthcare. POCT devices provide immediate diagnostic results, enabling faster clinical decision-making in hospitals, clinics, and even home settings. Moreover, technological advancements such as miniaturized biosensors, smartphone integration, and AI-driven analytics are enhancing the efficiency and usability of POCT devices, thereby boosting market adoption globally.

Drivers

Growing Prevalence of Chronic & Infectious Diseases

The increasing incidence of diabetes, cardiovascular diseases, respiratory infections, and emerging infectious diseases like COVID-19 and influenza is driving demand for quick and reliable diagnostic solutions at the patient’s location.

Technological Advancements in POCT Devices

Continuous innovation, including wireless connectivity, cloud-based data management, and portable molecular testing platforms, is improving the accuracy and accessibility of POCT devices, enhancing their adoption across various healthcare settings.

Shift Toward Decentralized Healthcare & Home Testing

The move toward home-based care and remote patient monitoring is fueling demand for compact, easy-to-use POCT devices, especially in aging populations and rural healthcare systems.

Restraints

High Cost of Advanced POCT Devices

While basic POCT devices are affordable, advanced molecular diagnostic platforms have a higher cost, limiting their adoption in low-resource settings.

Regulatory & Quality Concerns

Variability in test accuracy and stringent regulatory requirements for approval can delay commercialization and widespread adoption of POCT devices.

Opportunities

Rising Demand in Emerging Markets

Rapid healthcare infrastructure development and increasing awareness of early disease diagnosis in Asia-Pacific, Latin America, and the Middle East present significant growth opportunities for POCT manufacturers.

Integration with Digital Health Platforms

Combining POCT devices with AI-driven diagnostic support, telemedicine, and cloud connectivity offers new avenues for personalized and connected healthcare solutions.

Pandemic Preparedness & Infectious Disease Surveillance

The need for rapid response to epidemics and pandemics is creating sustained demand for POCT solutions for early detection of infectious diseases.

Market by System Type Insights

Glucose Monitoring Devices held the largest market share in 2023 due to the high global prevalence of diabetes and the growing trend of self-monitoring of blood glucose.

However, Infectious Disease POCT Devices are expected to grow at the fastest rate, driven by the need for rapid detection of pathogens like COVID-19, influenza, and HIV.

Market by End-Use Insights

Hospitals & Clinics dominated the market in 2023, accounting for over 45% of total revenue, as these settings require immediate diagnostics for faster clinical decision-making.

Homecare & Remote Patient Monitoring is expected to witness the highest growth rate due to rising demand for personalized healthcare and self-testing solutions.

Market by Regional Insights

North America held the largest share in 2023, attributed to well-established healthcare infrastructure, high adoption of advanced diagnostics, and favorable reimbursement policies.

Asia-Pacific is expected to register the fastest CAGR, fueled by increasing healthcare investments, a rising patient population, and growing awareness of early disease detection.

Europe remains a significant market due to supportive government initiatives for point-of-care diagnostics and strong adoption in chronic disease management.

Competitive Scenario

Key players in the global POCT devices market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, QuidelOrtho Corporation, BD (Becton, Dickinson and Company), Chembio Diagnostics, bioMérieux, Nova Biomedical, and EKF Diagnostics.

These companies focus on product innovation, strategic collaborations, acquisitions, and integration of digital health technologies to strengthen their market position.

Abbott expanded its portfolio with next-generation molecular POCT devices for respiratory infections in 2024.

Roche Diagnostics introduced AI-driven data analytics for its POCT platforms, improving real-time disease management.

Siemens Healthineers partnered with telehealth providers to integrate POCT results into remote patient consultations.

Scope of Work – Global Point-of-Care Testing (POCT) Devices Market

Key Market Developments

2024: Abbott launched a next-generation handheld POCT platform for respiratory infections with cloud-based data sharing for real-time surveillance.

2024: QuidelOrtho partnered with a telehealth company to enable virtual consultations integrated with POCT diagnostics.

2025: Siemens Healthineers introduced AI-powered POCT data analytics to support clinical decision-making in hospitals and homecare settings.

FAQs

What is the current market size of the Global Point-of-Care Testing (POCT) Devices Market?

The market was valued at USD 40.2 billion in 2023.

What is the major growth driver of the Global Point-of-Care Testing (POCT) Devices Market?

The major driver is the increasing demand for rapid diagnostics and chronic disease management, supported by technological innovations.

Which is the largest region during the forecast period in the Global Point-of-Care Testing (POCT) Devices Market?

North America holds the largest market share, while Asia-Pacific is expected to grow fastest.

Which segment accounted for the largest market share in the Global Point-of-Care Testing (POCT) Devices Market?

Glucose Monitoring Devices accounted for the largest share in 2023.

Who are the key market players in the Global Point-of-Care Testing (POCT) Devices Market?

Key players include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, BD, QuidelOrtho, and bioMérieux.

Would you like me to also generate a visually formatted infographic-style summary for quick reference, or should I draf